Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

Zhicheng Yao; Shida Yang; Hongyou Zhao; Huike Yang; Xin Jiang

doi:10.1038/s41417-019-0082-1

Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

Zhicheng Yao
, Shida Yang
, Hongyou Zhao
, Huike Yang
, Xin Jiang^*

^*Corresponding author for this work

The People’s Hospital of Liaoning Province
Louisiana State University Health Sciences Center
Harbin Medical University

Research output: Contribution to journal › Comment/debate

Abstract

All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

Original language	English
Pages (from-to)	257
Number of pages	1
Journal	Cancer Gene Therapy
Volume	26
Issue number	7-8
DOIs	https://doi.org/10.1038/s41417-019-0082-1
Publication status	Published - 1 Jul 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41417-019-0082-1

Cite this

@article{267d9821fe6441fa9120a2dbe9ce9e19,

title = "Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)",

abstract = "All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People{\textquoteright}s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.",

author = "Zhicheng Yao and Shida Yang and Hongyou Zhao and Huike Yang and Xin Jiang",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature America, Inc.",

year = "2019",

month = jul,

day = "1",

doi = "10.1038/s41417-019-0082-1",

language = "English",

volume = "26",

pages = "257",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Springer Nature",

number = "7-8",

}

TY - JOUR

T1 - Author Correction

T2 - BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

AU - Yao, Zhicheng

AU - Yang, Shida

AU - Zhao, Hongyou

AU - Yang, Huike

AU - Jiang, Xin

PY - 2019/7/1

Y1 - 2019/7/1

N2 - All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

AB - All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

UR - https://www.scopus.com/pages/publications/85061236332

U2 - 10.1038/s41417-019-0082-1

DO - 10.1038/s41417-019-0082-1

M3 - Comment/debate

C2 - 30723270

AN - SCOPUS:85061236332

SN - 0929-1903

VL - 26

SP - 257

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 7-8

ER -

Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this